Chemoprophylaxis in contacts of patients with leprosy: Systematic review and meta-analysis

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 26, Issue 4, 2009, Pages 341-349

  Reveiz, Ludovic ^a   Buendía, Jefferson A ^a   Téllez, Diana ^a  

^a Sanitas University Foundation   (Colombia)

Author keywords

Chemoprophylaxis; Contact tracing; Leprosy; Meta analysis; Randomized clinical trials

Indexed keywords

DISEASE CONTROL; DISEASE INCIDENCE; DRUG; LEPROSY; META-ANALYSIS;

EID: 73449123358     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892009001000009     Document Type: Review

References (45)

1. World Health Organization. Chemotherapy of leprosy for control programmes: report of a WHO Study Group (WHO Technical Report Series, No. 675). Geneva: WHO; 1982.
2. World Health Organization. Elimination of leprosy as a public health problem (update). Wkly Epidemiol Rec. 1998;73:308-12.
3. Organización Mundial de la Salud. Guía para la eliminación de la lepra como problema de salud pública. Documento WHO/LEP/95.1. Geneva: OMS; 1995.
4. World Health Organization. Leprosy elimination. Geneva: WHO; 2006. Available from: http://www.who.int/lep/en/. Accessed January 2009.
5. World Health Organization. WHO/70. Press release. Geneva: WHO; 1999.
6. Noordeen SK. Eliminating leprosy as a public health problem. Is the optimism justified? World Health Forum. 1996;17:109-44.
7. Soper FL. El concepto de erradicación de las enfermedades transmisibles. Bol Oficina Sanit Panam. 1957;42:1-5.
8. World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities. Plan period: 2006-2010. Document WHO/CDS/CPE/CEE/2005.53. Geneva: WHO; 2005.
9. Doull JA, Guinto RS, Rodriguez JN, Bancroft H. The incidence of leprosy in Cordova and Talisay, Cebu, Philippines. Int J Lepr. 1942;10:107-31.
10. Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and metaanalysis. MILEP2 Study Group. Mucosal immunology of leprosy. J Infect. 2000;41:137-42.
11. Moschella SL. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol. 2004;51(3):417-26.
12. Cartel JL, Chanteau S, Boutin JP, Taylor R, Plichart R, Roux J, et al. Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampicin. Int J Lepr Other Mycobact Dis. 1989;57(4):810-6.
13. Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, et al. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampicin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis. 1992;60:416-20.
14. Bakker MI, Hatta M, Kwenang A, Van Benthem BH, Van Beers SM, Klatser PR, et al. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72:443-8.
15. Castro AA, Clark OAC, Atallah A. Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS). São Paulo Med J. 1997;115:1423-6.
16. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. J Epidemiol. 2002;31:150-3.
17. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 4.2.6. Chichester, UK: Wiley; 2006.
18. Higgins JPT, Altman DG, eds. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.0. Chichester, UK: Wiley; 2008. Available from: www.cochrane-handbook.org/. Accessed January 2009.
19. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. Br Med J. 2001;323(7303):42-6.
20. Dharmendra. Prophylactic value of DDS against leprosy: an interim report. Lepr India. 1965;37:1-20.
21. Noordeen SK. Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 81/2 years follow-up. Lepr India. 1977;49:504-9.
22. Noordeen SK, Neelan PN. Chemoprophylaxis among contacts of nonlepromatous leprosy. Lepr India. 1976;48(4 suppl):635-42.
23. Noordeen SK, Neelan PN, Munaf A. Chemoprophylaxis against leprosy with acedapsone. An interim report. Lepr India. 1980;52(1):97-103.
24. Sloan NR, Worth RM, Jano B, Fasal P, Shepard CC. Acedapsone in leprosy chemoprophylaxis: field trial in three high-prevalence villages in Micronesia. Int J Lepr Other Mycobact Dis. 1972;40(1):40-7.
25. Sloan NR, Worth RM, Jano B, Fasal P, Shepard CC. Repository acedapsone in leprosy chemoprophylaxis and treatment. Lancet. 1971;2(7723):525-6.
26. Guinto RS. Chemoprophylaxis and BCG vaccination against leprosy. Int J Lepr Other Mycobact Dis. 1966;34(3):313-6.
27. Karat AB, Jeevaratnam A, Karat S, Rao PS. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1971;39(4):838-41.
28. Otsyula Y, Ibworo C, Chum HJ. Four years' experience with dapsone as prophylaxis against leprosy. Lepr Rev. 1971;42(2):98-100.
29. Saikawa K. Study on prevention of leprosy. 2. Chemo-prophylaxis trial for leprosy household contact children. Jpn J Lepr. 1985;54(4):187-92.
30. Russell DA, Worth RM, Jano B, Fasal P, Shepard CC. Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia. Am J Trop Med Hyg. 1979;28(3):559-63.
31. Nguyen LN, Cartel JL, Grosset JH. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years. Lepr Rev. 2000;71Suppl:S33-5; discussion S35-6.
32. Vijayakumaran P, Krishnamurthy P, Rao P, Declerq E. Chemoprophylaxis against leprosy: expectations and methodology of a trial. Lepr Rev. 2000;71Suppl:S37-40; discussion S40-1.
33. Chemoprophylaxis in leprosy. Br Med J. 1966;1(5498):1252.
34. Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, et al. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampicin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis. 1992;60:416-20.
35. Ew J, Kim YS. Chemoprophylaxis of leprosy contacts with D. D. S. Yonsei Med J. 1966;7:47-51.
36. Fasal P, Fasal E, Levy L. Leprosy prophylaxis. JAMA. 1967;199(12):905-8.
37. Oskam L, Mi B. Report of the workshop on the use of chemoprophylaxis in the control of leprosy held in Amsterdam, the Netherlands on 14 December 2006. Lepr Rev. 2007;78(2):173-85.
38. Moet FJ, Pahan D, Oskam L, Richardus JH, COLEP Study Group. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. Br Med J. 2008;336(7647):761-4.
39. Oo KN, Yin NN, Han TT, Wai KT, Myint K, Gyi MM. Serological response to chemoprophylaxis in extended contacts in leprosy-a randomized controlled trial. Jpn J Lepr. 2008;77(1):3-10.
40. Wardekar RV. DDS prophylaxis against leprosy. Lepr India. 1967;39:155-9.
41. Noordeen SK. Chemoprophylaxis in leprosy. Lepr India. 1969;41:247-54.
42. Noordeen SK, Neelan PN. Extended studies on chemoprophylaxis against leprosy. Indian J Med Res. 1978;67:515-27.
43. Neelan PN, Noordeen SK, Sivaprasad N. Chemoprophylaxis against leprosy with acedapsone. Indian J Med Res. 1983;78:307-13.
44. Neelan PN, Sirumban P, Sivaprasad N. Limited duration acedapsone prophylaxis in leprosy. Indian J Lepr. 1986;58(2):251-6.
45. Guía de diagnostico y manejo de la Lepra. En guías de promoción de la salud y prevención de enfermedades en la salud pública. Tomo III. Bogotá, Colombia: Ministerio de la Protección Social; 2007. Available from: http://www.minproteccionsocial. gov. co/VBeContent/NewsDetail.asp?ID=16159&IDCompany=3. Accessed January 2009.